DC Investments Management, LLC - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 29 filers reported holding TSCAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
DC Investments Management, LLC ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$91,041
+2.4%
35,5630.0%0.11%
+11.8%
Q2 2023$88,908
+19.0%
35,5630.0%0.10%
+14.6%
Q1 2023$74,682
+35.5%
35,5630.0%0.09%
+27.1%
Q4 2022$55,123
-49.9%
35,5630.0%0.07%
-72.2%
Q3 2022$110,000
-1.8%
35,5630.0%0.25%
-0.8%
Q2 2022$112,000
+12.0%
35,5630.0%0.25%
+46.0%
Q1 2022$100,000
-37.5%
35,5630.0%0.17%
-23.3%
Q4 2021$160,000
-46.1%
35,5630.0%0.23%
-59.0%
Q3 2021$297,00035,5630.55%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DC Funds, LP 630,000$1,323,00030.82%
Deer Management Co. LLC 1,245,505$2,615,5610.24%
Simplify Asset Management Inc. 546,916$1,148,5240.16%
Alphabet Inc. 1,077,080$2,261,8680.12%
Newtyn Management, LLC 236,800$497,2800.10%
DC Investments Management, LLC 35,563$74,6820.09%
Privium Fund Management (UK) Ltd 15,825$40,9870.03%
Baker Brothers Advisors 2,784,792$5,848,0630.03%
Tekla Capital Management LLC 200,000$420,0000.02%
NewEdge Wealth, LLC 91,463$192,0720.01%
View complete list of TSCAN THERAPEUTICS INC shareholders